Marie Layzell

Marie Layzell

COO, Head of CMC

Marie has over 20 years’ experience in the pharmaceutical industry as an analytical scientist and consultant, and has advised multiple large pharmaceutical projects on CMC drug development. 

Graduating from the University of Hertfordshire in 1998 with a degree in human biology, she went on to work in numerous Contract Diagnostic Organizations including Prova (R&D) Ltd, Bodycote Testing and Exova Group. Marie has worked with Small Pharma since 2015 and assumed the role of Senior Research Manager heading up CMC activities in May 2016.

Her experience managing the CMC development for numerous small molecules and biological entities and supervising teams of analysts and working with formulators to progress development is central to Small Pharma’s commitment to applying safe science to create positive change.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: